Evercore ISI analyst Umer Raffat reinstates coverage on Biogen (NASDAQ: BIIB) with a Outperform rating.The analyst comments "That was a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage